Citation only
via OpenAlex
miRNAs in Alzheimer Disease - A Therapeutic Perspective
Priya Gupta, Surajit Bhattacharjee, Ashish Ranjan Sharma, Garima Sharma, Sang‐Soo Lee, Chiranjib Chakraborty
Current Alzheimer Research · 2017 · ▲ 115 citations
Abstract
BACKGROUND: Alzheimer's disease is a neurodegenerative disorder which generally affects people who are more than 60 years of age. The disease is clinically characterised by dementia, loss of cognitive functions and massive neurodegeneration. The presence of neurofibrilary tangles and amyloid plaques in the hippocampal region of the brain are the hallmarks of the disease. Current therapeutic approaches for the treatment of Alzheimer's disease are symptomatic and disease modifying, none of which provide any permanent solution or cure for the disease. Dysregulation of miRNAs is one of the major causes of neurodegeneration. CONCLUSION: In the present review, the roles of different miRNAs such as miR-9, miR-107, miR-29, miR-34, miR-181, miR-106, miR-146a, miR132, miR124a, miR153 has been discussed in detail in the pathogenesis of various neurodegenerative diseases with special focus on AD. The probability of miRNAs as an alternative and more sensitive approach for detection and management of the AD has also been discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/1567205014666170829101016
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Gupta, P., Bhattacharjee, S., Sharma, A.R., Sharma, G., Lee, S., & Chakraborty, C. (2017). miRNAs in Alzheimer Disease - A Therapeutic Perspective. <em>Current Alzheimer Research</em>. https://doi.org/10.2174/1567205014666170829101016
Vancouver
Gupta P, Bhattacharjee S, Sharma AR, Sharma G, Lee S, Chakraborty C. miRNAs in Alzheimer Disease - A Therapeutic Perspective. Current Alzheimer Research. 2017. doi:10.2174/1567205014666170829101016.
BibTeX
@article{priya2017miRNAs,
title = {miRNAs in Alzheimer Disease - A Therapeutic Perspective},
author = {Priya Gupta and Surajit Bhattacharjee and Ashish Ranjan Sharma and Garima Sharma and Sang‐Soo Lee and Chiranjib Chakraborty},
journal = {Current Alzheimer Research},
year = {2017},
doi = {10.2174/1567205014666170829101016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet Neurology 2016
Citation only
Alzheimer's disease risk: amyloid versus neurodegeneration
European Journal of Medicinal Chemistry 2021
Citation only
Alzheimer’s disease and its treatment by different approaches: A review
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Journal of Neural Transmission 2017
Preprint · OA
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
Springer eBooks 2008
Citation only
Amyloid and Neurodegeneration: Alzheimer's Disease and Retinal Degeneration
Neurobiology of Disease 2020
Open access · CC-BY